AbbVie (ABBV)Rep. John James (MI10) disclosed a sale $1K–$15K
Rep. John James (MI10) disclosed a sale of AbbVie in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 2 days
- Disclosure lag
- Traded
- Sep 4, 2024
- Disclosed
- Sep 6, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 10, 2023CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
- Jul 2, 2024CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
- Sep 4, 2024 · this disclosureCongressDisclosed sale of ABBV — reported range $1,001 - $15,000
What came next
- Sep 16, 2024FDARecall: Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Mad…
- Sep 16, 2024FDARecall: Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie compan…
- Oct 16, 2024FDAFDA drug approval: Vyalev
- Oct 18, 2024FDAFDA drug approval: Botox Cosmetic
- Nov 20, 2024CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
- Dec 16, 2024InsiderOfficer sold ~$310K of ABBV shares in the open market
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for AbbVie
For AbbVie, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 130 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABBV page.
Other recent filings by Rep. John James (MI10)
- House Clerk periodic transaction report at EOG Resources (EOG)Sep 6, 2024
- House Clerk periodic transaction report at Fidelity National Financial (FNF)Sep 6, 2024
- House Clerk periodic transaction report at Microchip Technology (MCHP)Sep 6, 2024
- House Clerk periodic transaction report at Abbott Laboratories (ABT)Sep 6, 2024
- House Clerk periodic transaction report at Accenture (ACN)Sep 6, 2024
The full history of Rep. John James (MI10) is on the profile page.
How this filing works
Other disclosures at AbbVie
- House Clerk periodic transaction reportSep 18, 2026
- SEC Form 13F-HRAug 26, 2026
- SEC Form 13F-HRAug 25, 2026
- SEC Form 4Aug 18, 2026
- SEC Form 13F-HRAug 17, 2026
- SEC Form 144Aug 14, 2026
Everything OQRO holds on this company is on its ABBV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
